Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Research
Biotech
After R&D head exits, Immunocore CEO pairs ambition with caution
CEO Bahija Jallal now has to advance Immunocore's ascending franchise without one of its key architects.
Darren Incorvaia
Feb 13, 2026 12:44pm
Langer-backed biotech looks to end cancer recurrence
Feb 12, 2026 8:00am
Allogeneic CAR-T biotechs fight to escape 'nuclear winter'
Feb 11, 2026 11:00am
BMS and Evinova pen global development partnership
Feb 9, 2026 2:33pm
Jay Bhattacharya faces Senate grilling on NIH disruptions
Feb 3, 2026 5:20pm
HHS launches $100M prize to develop antiviral therapies
Feb 3, 2026 4:00pm
